|
|
|
| Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more |
|
|
|
|
By Drug Delivery Leader: Sit And Deliver | In this episode of Sit and Deliver, host Tom von Gunden talks with Jared and Joel Stanley, from botanical therapeutics development company DeFloria, about cannabinoid-based therapies targeting Autism Spectrum Disorder (ASD). The discussion covers aspects of drug development and delivery, including dosing for oral administration, as well as key considerations for commercial-scale production and distribution of regulated botanicals. | |
|
|
|
|
| A New Mindset For Combination Product Development | Article | By Asmita Khanolkar, SMC Ltd. | As we balance the time-to-market and risk for novel therapies, we must anticipate changing needs for combination device development, highlighting the technological paradigm shift. |
|
|
| Improving Toxicology Testing For Inhalation Products | Article | Battelle | By embracing new approach methods, regulatory agencies can revolutionize toxicology testing. These methods can be adapted for various medications, including inhalers and nasal-administered drugs. |
|
|
|
|
|
|
|
|
|
.png){kind=logo}
